Lidocaine effects on the laryngeal chemoreflex, mechanoreflex, and afferent electrical stimulation reflex

T. M. McCulloch, M. A. Richardson, Paul Flint, M. J. Bishop

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

The use of lidocaine hydrochloride as either a topical or intravenous agent has become a common practice for minimizing laryngospasm and the reflex cardiovascular effects resulting from upper airway manipulation. The efficacy and mechanism of action of lidocaine for this purpose remain unclear. We evaluated the effect of lidocaine on the laryngeal chemoreflex (LCR), mechanoreflex (LMR), and superior laryngeal nerve electrical stimulation adductor reflex (SLN-ESAR) in piglets. Cardiopulmonary responses were used to assess LCR and LMR. Latency following SLN stimulation was used to assess SLN- ESAR. Intravenous lidocaine hydrochloride at 3 mg/kg produced no suppression of the LCR, LMR, or latency (SLN-ESAR onset latency before lidocaine 11.7 ± 0.7 milliseconds, after lidocaine 12.2 ± 0.5 milliseconds; peak latency before lidocaine 13.2 ± 0.2 milliseconds, after lidocaine 13.4 ± 0.4 milliseconds). Topically applied lidocaine at the same dose eliminated both LCR and LMR responses in all animals, with return of reflex responses 15 minutes after application. No effect on the SLN-ESAR was seen with application of topical lidocaine. This study supports topical lidocaine as a suppressant of laryngeal mucosal neuroreceptors without central neural reflex effects. Intravenous lidocaine did not affect peripheral neuroreceptors, nor did it significantly affect the latency of the SLN-ESAR neural reflex arc. Intravenous and topical lidocaine differ in mechanism of action and efficacy with regard to modulation of reflex effects induced by laryngeal stimulation.

Original languageEnglish (US)
Pages (from-to)583-589
Number of pages7
JournalAnnals of Otology, Rhinology and Laryngology
Volume101
Issue number7
StatePublished - 1992
Externally publishedYes

Fingerprint

Lidocaine
Electric Stimulation
Reflex
Laryngeal Nerves
Sensory Receptor Cells
Laryngismus

Keywords

  • laryngeal adductor reflex
  • laryngeal chemoreflex
  • laryngeal mechanoreceptor
  • larynx
  • lidocaine
  • piglet

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Lidocaine effects on the laryngeal chemoreflex, mechanoreflex, and afferent electrical stimulation reflex. / McCulloch, T. M.; Richardson, M. A.; Flint, Paul; Bishop, M. J.

In: Annals of Otology, Rhinology and Laryngology, Vol. 101, No. 7, 1992, p. 583-589.

Research output: Contribution to journalArticle

@article{c34afad1cee644619d4ee642e0313ac3,
title = "Lidocaine effects on the laryngeal chemoreflex, mechanoreflex, and afferent electrical stimulation reflex",
abstract = "The use of lidocaine hydrochloride as either a topical or intravenous agent has become a common practice for minimizing laryngospasm and the reflex cardiovascular effects resulting from upper airway manipulation. The efficacy and mechanism of action of lidocaine for this purpose remain unclear. We evaluated the effect of lidocaine on the laryngeal chemoreflex (LCR), mechanoreflex (LMR), and superior laryngeal nerve electrical stimulation adductor reflex (SLN-ESAR) in piglets. Cardiopulmonary responses were used to assess LCR and LMR. Latency following SLN stimulation was used to assess SLN- ESAR. Intravenous lidocaine hydrochloride at 3 mg/kg produced no suppression of the LCR, LMR, or latency (SLN-ESAR onset latency before lidocaine 11.7 ± 0.7 milliseconds, after lidocaine 12.2 ± 0.5 milliseconds; peak latency before lidocaine 13.2 ± 0.2 milliseconds, after lidocaine 13.4 ± 0.4 milliseconds). Topically applied lidocaine at the same dose eliminated both LCR and LMR responses in all animals, with return of reflex responses 15 minutes after application. No effect on the SLN-ESAR was seen with application of topical lidocaine. This study supports topical lidocaine as a suppressant of laryngeal mucosal neuroreceptors without central neural reflex effects. Intravenous lidocaine did not affect peripheral neuroreceptors, nor did it significantly affect the latency of the SLN-ESAR neural reflex arc. Intravenous and topical lidocaine differ in mechanism of action and efficacy with regard to modulation of reflex effects induced by laryngeal stimulation.",
keywords = "laryngeal adductor reflex, laryngeal chemoreflex, laryngeal mechanoreceptor, larynx, lidocaine, piglet",
author = "McCulloch, {T. M.} and Richardson, {M. A.} and Paul Flint and Bishop, {M. J.}",
year = "1992",
language = "English (US)",
volume = "101",
pages = "583--589",
journal = "Annals of Otology, Rhinology and Laryngology",
issn = "0003-4894",
publisher = "Annals Publishing Company",
number = "7",

}

TY - JOUR

T1 - Lidocaine effects on the laryngeal chemoreflex, mechanoreflex, and afferent electrical stimulation reflex

AU - McCulloch, T. M.

AU - Richardson, M. A.

AU - Flint, Paul

AU - Bishop, M. J.

PY - 1992

Y1 - 1992

N2 - The use of lidocaine hydrochloride as either a topical or intravenous agent has become a common practice for minimizing laryngospasm and the reflex cardiovascular effects resulting from upper airway manipulation. The efficacy and mechanism of action of lidocaine for this purpose remain unclear. We evaluated the effect of lidocaine on the laryngeal chemoreflex (LCR), mechanoreflex (LMR), and superior laryngeal nerve electrical stimulation adductor reflex (SLN-ESAR) in piglets. Cardiopulmonary responses were used to assess LCR and LMR. Latency following SLN stimulation was used to assess SLN- ESAR. Intravenous lidocaine hydrochloride at 3 mg/kg produced no suppression of the LCR, LMR, or latency (SLN-ESAR onset latency before lidocaine 11.7 ± 0.7 milliseconds, after lidocaine 12.2 ± 0.5 milliseconds; peak latency before lidocaine 13.2 ± 0.2 milliseconds, after lidocaine 13.4 ± 0.4 milliseconds). Topically applied lidocaine at the same dose eliminated both LCR and LMR responses in all animals, with return of reflex responses 15 minutes after application. No effect on the SLN-ESAR was seen with application of topical lidocaine. This study supports topical lidocaine as a suppressant of laryngeal mucosal neuroreceptors without central neural reflex effects. Intravenous lidocaine did not affect peripheral neuroreceptors, nor did it significantly affect the latency of the SLN-ESAR neural reflex arc. Intravenous and topical lidocaine differ in mechanism of action and efficacy with regard to modulation of reflex effects induced by laryngeal stimulation.

AB - The use of lidocaine hydrochloride as either a topical or intravenous agent has become a common practice for minimizing laryngospasm and the reflex cardiovascular effects resulting from upper airway manipulation. The efficacy and mechanism of action of lidocaine for this purpose remain unclear. We evaluated the effect of lidocaine on the laryngeal chemoreflex (LCR), mechanoreflex (LMR), and superior laryngeal nerve electrical stimulation adductor reflex (SLN-ESAR) in piglets. Cardiopulmonary responses were used to assess LCR and LMR. Latency following SLN stimulation was used to assess SLN- ESAR. Intravenous lidocaine hydrochloride at 3 mg/kg produced no suppression of the LCR, LMR, or latency (SLN-ESAR onset latency before lidocaine 11.7 ± 0.7 milliseconds, after lidocaine 12.2 ± 0.5 milliseconds; peak latency before lidocaine 13.2 ± 0.2 milliseconds, after lidocaine 13.4 ± 0.4 milliseconds). Topically applied lidocaine at the same dose eliminated both LCR and LMR responses in all animals, with return of reflex responses 15 minutes after application. No effect on the SLN-ESAR was seen with application of topical lidocaine. This study supports topical lidocaine as a suppressant of laryngeal mucosal neuroreceptors without central neural reflex effects. Intravenous lidocaine did not affect peripheral neuroreceptors, nor did it significantly affect the latency of the SLN-ESAR neural reflex arc. Intravenous and topical lidocaine differ in mechanism of action and efficacy with regard to modulation of reflex effects induced by laryngeal stimulation.

KW - laryngeal adductor reflex

KW - laryngeal chemoreflex

KW - laryngeal mechanoreceptor

KW - larynx

KW - lidocaine

KW - piglet

UR - http://www.scopus.com/inward/record.url?scp=0026690398&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026690398&partnerID=8YFLogxK

M3 - Article

C2 - 1626904

AN - SCOPUS:0026690398

VL - 101

SP - 583

EP - 589

JO - Annals of Otology, Rhinology and Laryngology

JF - Annals of Otology, Rhinology and Laryngology

SN - 0003-4894

IS - 7

ER -